HEADER BLOOD CLOTTING, HYDROLASE 11-MAY-22 7V12 TITLE FACTOR XIA IN COMPLEX WITH COMPOUND 2F COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XIA LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA; COMPND 5 EC: 3.4.21.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F11; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS HYDROLASE, SERINE PROTEASE, COAGULATION FACTOR, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR P.L.SHAFFER,J.SPURLINO,C.M.MILLIGAN REVDAT 3 18-OCT-23 7V12 1 REMARK REVDAT 2 24-AUG-22 7V12 1 JRNL REVDAT 1 03-AUG-22 7V12 0 JRNL AUTH G.XU,Z.LIU,X.WANG,T.LU,R.L.DESJARLAIS,T.THIEU,J.ZHANG, JRNL AUTH 2 Z.H.DEVINE,F.DU,Q.LI,C.M.MILLIGAN,P.SHAFFER,P.E.CEDERVALL, JRNL AUTH 3 J.C.SPURLINO,C.F.STRATTON,B.PIETRAK,L.M.SZEWCZUK,V.WONG, JRNL AUTH 4 R.A.STEELE,W.BRUINZEEL,M.CHINTALA,J.SILVA,M.D.GAUL, JRNL AUTH 5 M.J.MACIELAG,R.NARGUND JRNL TITL DISCOVERY OF POTENT AND ORALLY BIOAVAILABLE PYRIDINE JRNL TITL 2 N-OXIDE-BASED FACTOR XIA INHIBITORS THROUGH EXPLOITING JRNL TITL 3 NONCLASSICAL INTERACTIONS. JRNL REF J.MED.CHEM. V. 65 10419 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35862732 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00442 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 3 NUMBER OF REFLECTIONS : 25786 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.690 REMARK 3 FREE R VALUE TEST SET COUNT : 1982 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.7960 - 3.9311 1.00 2094 175 0.1610 0.1876 REMARK 3 2 3.9311 - 3.1205 0.99 1990 168 0.1582 0.2080 REMARK 3 3 3.1205 - 2.7262 0.99 1961 167 0.1924 0.2142 REMARK 3 4 2.7262 - 2.4769 0.99 1946 161 0.1891 0.2463 REMARK 3 5 2.4769 - 2.2994 0.98 1918 166 0.1889 0.2425 REMARK 3 6 2.2994 - 2.1639 0.92 1800 146 0.1866 0.2192 REMARK 3 7 2.1639 - 2.0555 0.89 1733 138 0.1923 0.2480 REMARK 3 8 2.0555 - 1.9660 0.85 1649 139 0.1832 0.2201 REMARK 3 9 1.9660 - 1.8903 0.81 1575 134 0.1922 0.2500 REMARK 3 10 1.8903 - 1.8251 0.78 1509 128 0.2032 0.2219 REMARK 3 11 1.8251 - 1.7680 0.76 1474 113 0.2114 0.2351 REMARK 3 12 1.7680 - 1.7175 0.74 1420 126 0.2409 0.3155 REMARK 3 13 1.7175 - 1.6723 0.73 1388 113 0.2701 0.3631 REMARK 3 14 1.6723 - 1.6315 0.69 1347 108 0.3205 0.3449 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 1997 REMARK 3 ANGLE : 1.009 2720 REMARK 3 CHIRALITY : 0.070 284 REMARK 3 PLANARITY : 0.006 356 REMARK 3 DIHEDRAL : 14.795 1163 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 388 THROUGH 491 ) REMARK 3 ORIGIN FOR THE GROUP (A): -22.8504 -15.4101 13.2230 REMARK 3 T TENSOR REMARK 3 T11: 0.1044 T22: 0.1029 REMARK 3 T33: 0.0997 T12: 0.0020 REMARK 3 T13: 0.0175 T23: 0.0040 REMARK 3 L TENSOR REMARK 3 L11: 0.9069 L22: 0.9960 REMARK 3 L33: 0.4463 L12: -0.0035 REMARK 3 L13: 0.1816 L23: 0.2797 REMARK 3 S TENSOR REMARK 3 S11: -0.0169 S12: -0.0224 S13: -0.1128 REMARK 3 S21: 0.0634 S22: -0.0048 S23: 0.1049 REMARK 3 S31: 0.1026 S32: -0.0005 S33: -0.0007 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 492 THROUGH 518 ) REMARK 3 ORIGIN FOR THE GROUP (A): -19.5822 1.5086 15.7211 REMARK 3 T TENSOR REMARK 3 T11: 0.1497 T22: 0.1243 REMARK 3 T33: 0.1614 T12: -0.0159 REMARK 3 T13: 0.0224 T23: 0.0056 REMARK 3 L TENSOR REMARK 3 L11: 0.2395 L22: 0.0875 REMARK 3 L33: 0.0685 L12: -0.0854 REMARK 3 L13: 0.0772 L23: 0.0306 REMARK 3 S TENSOR REMARK 3 S11: -0.0536 S12: -0.0495 S13: 0.3234 REMARK 3 S21: 0.0577 S22: 0.1449 S23: 0.0209 REMARK 3 S31: -0.1536 S32: -0.0213 S33: 0.0020 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 519 THROUGH 623 ) REMARK 3 ORIGIN FOR THE GROUP (A): -9.0513 -6.1884 11.9057 REMARK 3 T TENSOR REMARK 3 T11: 0.0862 T22: 0.0995 REMARK 3 T33: 0.1004 T12: 0.0010 REMARK 3 T13: 0.0019 T23: -0.0186 REMARK 3 L TENSOR REMARK 3 L11: 1.0654 L22: 0.5098 REMARK 3 L33: 0.8596 L12: 0.0125 REMARK 3 L13: -0.3776 L23: 0.1212 REMARK 3 S TENSOR REMARK 3 S11: 0.0565 S12: -0.0941 S13: 0.0268 REMARK 3 S21: 0.0299 S22: 0.0490 S23: -0.1254 REMARK 3 S31: -0.0400 S32: 0.1599 S33: 0.1958 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7V12 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265303. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25830 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.84700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.10 REMARK 200 STARTING MODEL: 3SOS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG 4000, 100MM NA CITRATE PH 5.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.30200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.34300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.81350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.34300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.30200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.81350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 624 REMARK 465 VAL A 625 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 491 O HOH A 801 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 526 -139.37 -154.48 REMARK 500 SER A 594 -60.84 -127.06 REMARK 500 REMARK 500 REMARK: NULL DBREF 7V12 A 388 625 UNP P03951 FA11_HUMAN 388 625 SEQADV 7V12 SER A 500 UNP P03951 CYS 500 ENGINEERED MUTATION SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 A 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 A 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 A 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 238 THR GLN ALA VAL HET OR0 A 701 58 HET CIT A 702 18 HETNAM OR0 5-[1-[(1~{R})-1-[5-[3-CHLORANYL-2-FLUORANYL-6-(1,2,3,4- HETNAM 2 OR0 TETRAZOL-1-YL)PHENYL]-1-OXIDANYL-PYRIDIN-2-YL]-2- HETNAM 3 OR0 CYCLOPROPYL-ETHYL]PYRAZOL-4-YL]-6-FLUORANYL-PYRIDIN-2- HETNAM 4 OR0 AMINE HETNAM CIT CITRIC ACID FORMUL 2 OR0 C25 H20 CL F2 N9 O FORMUL 3 CIT C6 H8 O7 FORMUL 4 HOH *112(H2 O) HELIX 1 AA1 ALA A 429 TYR A 434 5 6 HELIX 2 AA2 SER A 438 LYS A 440 5 3 HELIX 3 AA3 ASN A 450 ILE A 454 5 5 HELIX 4 AA4 MET A 474 GLY A 478 5 5 HELIX 5 AA5 THR A 541 TYR A 549 1 9 HELIX 6 AA6 TYR A 614 GLN A 623 1 10 SHEET 1 AA1 8 THR A 392 ALA A 393 0 SHEET 2 AA1 8 GLN A 533 LYS A 536 -1 O LYS A 534 N THR A 392 SHEET 3 AA1 8 CYS A 514 GLY A 518 -1 N VAL A 516 O ALA A 535 SHEET 4 AA1 8 PRO A 578 HIS A 583 -1 O SER A 580 N TRP A 515 SHEET 5 AA1 8 VAL A 586 TRP A 595 -1 O VAL A 586 N HIS A 583 SHEET 6 AA1 8 GLY A 606 ASN A 610 -1 O VAL A 607 N TRP A 595 SHEET 7 AA1 8 MET A 558 ALA A 561 -1 N ILE A 559 O TYR A 608 SHEET 8 AA1 8 LEU A 539 VAL A 540 -1 N VAL A 540 O CYS A 560 SHEET 1 AA2 6 LEU A 442 SER A 446 0 SHEET 2 AA2 6 GLN A 402 THR A 407 -1 N HIS A 406 O ARG A 443 SHEET 3 AA2 6 ARG A 413 GLY A 422 -1 O LEU A 415 N LEU A 405 SHEET 4 AA2 6 TRP A 425 THR A 428 -1 O LEU A 427 N SER A 419 SHEET 5 AA2 6 ALA A 482 LEU A 486 -1 O ALA A 482 N THR A 428 SHEET 6 AA2 6 VAL A 463 ILE A 468 -1 N ILE A 467 O LEU A 483 SSBOND 1 CYS A 416 CYS A 432 1555 1555 2.02 SSBOND 2 CYS A 514 CYS A 581 1555 1555 2.05 SSBOND 3 CYS A 545 CYS A 560 1555 1555 2.02 SSBOND 4 CYS A 571 CYS A 599 1555 1555 2.02 CISPEP 1 SER A 409 PRO A 410 0 -0.41 CRYST1 58.604 59.627 66.686 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017064 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016771 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014996 0.00000